Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Target Controlled Infusion Using Propofol and Remifentanil for Moderate Sedation in Dentistry

NCT03995134 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT03995134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03995134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Target Controlled Infusion Using Propofol and Remifentanil for Moderate Sedation in Dentistry
Lead sponsor
University of Alberta
Phase
Observational
Overall status
Completed
Start date
August 3, 2019
Completion date
January 17, 2020
Enrollment
101 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sedative adverse reaction